Adipocytokines and hepatic fibrosis. (March 2015)

• Record Type: Journal Article
• Authors: Saxena, Neeraj K.; Anania, Frank A.
• Is Part Of: Trends in endocrinology and metabolism. Volume 26:Number 3(2015)
• Page Start: 153
• Page End: 161
• Publication Date: 2015-03
• Subjects: Endocrinology -- Periodicals; Metabolism -- Periodicals; Metabolism; 616.4
• DOI: 10.1016/j.tem.2015.01.002
• Languages: English
• ISSNs: 1043-2760

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">Hepatic fibrosis, although reversible, can lead to cirrhosis if unchecked.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">Clinical therapy to prevent liver fibrosis progression is not available.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">Cirrhosis poses a significant increased risk for development of hepatocellular carcinoma.</p> </list-item> <list-item id="lsti0020"> <label></label> <p id="par0020">Measurements of key cytokines could be useful biomarkers of predicting NAFLD patients likely to have disease progression.</p> </list-item> </list> </p> </sec> </abstract>